ReviewCancer immunology, immunotherapy : CII2024

GPCRs: emerging targets for novel T cell immune checkpoint therapy.

Kaitlyn Dickinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.